Daratumumab-based treatment for immunoglobulin light-chain amyloidosis

the ANDROMEDA Trial Investigators

Research output: Contribution to journalArticlepeer-review

285 Scopus citations

Fingerprint

Dive into the research topics of 'Daratumumab-based treatment for immunoglobulin light-chain amyloidosis'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology